N6AMT1 is a novel potential diagnostic, prognostic and immunotherapy response biomarker in pan-cancer.

Wang, Mingqi; Zhu, Jiajie; Ye, Yingquan; Li, Ping; Sun, Weijie; Zhang, Mei

Wang, Mingqi; Zhu, Jiajie; Ye, Yingquan; Li, Ping; Sun, Weijie; Zhang, Mei.

Affiliation

Wang M; Department of Chinese Integrative Medicine Oncology, The First Affiliated Hospital of Anhui Medical University, Shushan, Hefei 230022, Anhui, China.
Zhu J; Department of Integrated Traditional Chinese and Western Medicine, Anhui Medical University, Shushan, Hefei 230022, Anhui, China.
Ye Y; Department of Gastroenterology, Tongde Hospital of Zhejiang Province, Xihu, Hangzhou 310012, Zhejiang, China.
Li P; Department of Chinese Integrative Medicine Oncology, The First Affiliated Hospital of Anhui Medical University, Shushan, Hefei 230022, Anhui, China.
Sun W; Department of Integrated Traditional Chinese and Western Medicine, Anhui Medical University, Shushan, Hefei 230022, Anhui, China.
Zhang M; Department of Chinese Integrative Medicine Oncology, The First Affiliated Hospital of Anhui Medical University, Shushan, Hefei 230022, Anhui, China.

Aging (Albany NY) ; 15(13): 6526-6544, 2023 07 12.

Article de En | MEDLINE | ID: mdl-37437243

Sujet(s)
Mots clés

N6AMT1; diagnosis; immunotherapy; pan-cancer; prognosis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Aging (Albany NY) Sujet du journal: GERIATRIA Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google